Aimee G Costello1, Bethany D Nugent2,3, Noelle Conover1,3, Amanda Moore1, Kathleen Dempsey1, Jean M Tersak1,3. 1. 1 Division of Hematology, Oncology, and Blood and Marrow Transplant, Children's Hospital of Pittsburgh of UPMC , Pittsburgh, Pennsylvania. 2. 2 School of Nursing, University of Pittsburgh , Pittsburgh, Pennsylvania. 3. 3 Department of Pediatrics, University of Pittsburgh , Pittsburgh, Pennsylvania.
Abstract
PURPOSE: With an increasing number of childhood cancer survivors (CCSs), determining the best model of survivorship transition care is becoming a growing priority. Shared care between pediatric oncology and adult primary care is often necessary, making survivorship a time of transition, but effective standard models are lacking. We sought to provide a more integrated approach to transition using telemedicine. METHODS: Recruited primary care provider/CCS dyads were instructed to log-in to a password-protected virtual meeting room using telemedicine equipment at the time or a regularly scheduled office visit. Dyads were joined by a pediatric survivorship clinic team member who conducted the telemedicine portion of the transition visit, which consisted of the review of an individualized treatment summary and care plan. Postquestionnaires were developed to evaluate key points such as fund of knowledge, satisfaction with the visit, and effectiveness of this electronic tool. RESULTS: There were 19 transition visits conducted, 13 of which used the telemedicine equipment as planned. Those that did not use the equipment were primarily unable to due to technical difficulties. Postquestionnaires were overall positive, confirming increased knowledge, comfort and abilities, and patient satisfaction in survivorship care. Negative comments were primarily related to equipment difficulties. CONCLUSIONS: A gap still remains in helping CCSs transition from oncology to primary care and this pilot study offered insights into how we might better bridge that gap through the use of telemedicine. Further research is needed to refine the transition process for CCSs, including evaluation and testing models for standard of care.
PURPOSE: With an increasing number of childhood cancer survivors (CCSs), determining the best model of survivorship transition care is becoming a growing priority. Shared care between pediatric oncology and adult primary care is often necessary, making survivorship a time of transition, but effective standard models are lacking. We sought to provide a more integrated approach to transition using telemedicine. METHODS: Recruited primary care provider/CCS dyads were instructed to log-in to a password-protected virtual meeting room using telemedicine equipment at the time or a regularly scheduled office visit. Dyads were joined by a pediatric survivorship clinic team member who conducted the telemedicine portion of the transition visit, which consisted of the review of an individualized treatment summary and care plan. Postquestionnaires were developed to evaluate key points such as fund of knowledge, satisfaction with the visit, and effectiveness of this electronic tool. RESULTS: There were 19 transition visits conducted, 13 of which used the telemedicine equipment as planned. Those that did not use the equipment were primarily unable to due to technical difficulties. Postquestionnaires were overall positive, confirming increased knowledge, comfort and abilities, and patient satisfaction in survivorship care. Negative comments were primarily related to equipment difficulties. CONCLUSIONS: A gap still remains in helping CCSs transition from oncology to primary care and this pilot study offered insights into how we might better bridge that gap through the use of telemedicine. Further research is needed to refine the transition process for CCSs, including evaluation and testing models for standard of care.
Entities:
Keywords:
childhood cancer; late effects; primary care; survivorship; telemedicine; transition
Authors: Anne E Kazak; Matthew C Hocking; Richard F Ittenbach; Anna T Meadows; Wendy Hobbie; Branlyn Werba DeRosa; Ann Leahey; Leslie Kersun; Anne Reilly Journal: Pediatr Blood Cancer Date: 2011-08-19 Impact factor: 3.167
Authors: Arnold L Potosky; Paul K J Han; Julia Rowland; Carrie N Klabunde; Tenbroeck Smith; Noreen Aziz; Craig Earle; John Z Ayanian; Patricia A Ganz; Michael Stefanek Journal: J Gen Intern Med Date: 2011-07-22 Impact factor: 5.128
Authors: Alaina M Davis; Rebekah F Brown; Julie Lounds Taylor; Richard A Epstein; Melissa L McPheeters Journal: Pediatrics Date: 2014-10-06 Impact factor: 7.124
Authors: Winson Y Cheung; Bridget A Neville; Danielle B Cameron; E Francis Cook; Craig C Earle Journal: J Clin Oncol Date: 2009-03-30 Impact factor: 44.544
Authors: Paul C Nathan; Mark L Greenberg; Kirsten K Ness; Melissa M Hudson; Ann C Mertens; Martin C Mahoney; James G Gurney; Sarah S Donaldson; Wendy M Leisenring; Leslie L Robison; Kevin C Oeffinger Journal: J Clin Oncol Date: 2008-09-20 Impact factor: 50.717
Authors: Maria Otth; Sibylle Denzler; Christa Koenig; Henrik Koehler; Katrin Scheinemann Journal: J Cancer Surviv Date: 2020-07-16 Impact factor: 4.442
Authors: Claire Snyder; Youngjee Choi; Katherine C Smith; Renee F Wilson; Christina T Yuan; Paul C Nathan; Allen Zhang; Karen A Robinson Journal: JNCI Cancer Spectr Date: 2022-03-02
Authors: Eric J Chow; Kirsten K Ness; Gregory T Armstrong; Nickhill Bhakta; Jennifer M Yeh; Smita Bhatia; Wendy Landier; Louis S Constine; Melissa M Hudson; Paul C Nathan Journal: Semin Oncol Date: 2020-03-04 Impact factor: 4.929
Authors: Lisa B Kenney; Lynda M Vrooman; Eileen Duffey Lind; Jill Brace-O'Neill; Jean E Mulder; Larissa Nekhlyudov; Christopher J Recklitis Journal: Pediatr Blood Cancer Date: 2021-02-08 Impact factor: 3.838
Authors: Selina R van den Oever; Saskia M F Pluijm; Rod Skinner; Adam Glaser; Renée L Mulder; Saro Armenian; Edit Bardi; Claire Berger; Matthew J Ehrhardt; Jordan Gilleland Marchak; Gabrielle M Haeusler; Jaap den Hartogh; Lars Hjorth; Tomas Kepak; Izolda Kriviene; Thorsten Langer; Miho Maeda; Catalina Márquez-Vega; Gisela Michel; Monica Muraca; Mohamed Najib; Paul C Nathan; Anna Panasiuk; Maya Prasad; Jelena Roganovic; Anne Uyttebroeck; Jeanette F Winther; Lorna Zadravec Zaletel; Elvira C van Dalen; Helena J H van der Pal; Melissa M Hudson; Leontien C M Kremer Journal: J Cancer Surviv Date: 2022-01-12 Impact factor: 4.442
Authors: Michael J Maniaci; Ricardo A Torres-Guzman; John P Garcia; Francisco R Avila; Karla C Maita; Antonio J Forte; Margaret R Paulson Journal: SAGE Open Med Date: 2022-04-22
Authors: Kyleigh Schraeder; Brooke Allemang; Ashley N Felske; Cathie M Scott; Kerry A McBrien; Gina Dimitropoulos; Susan Samuel Journal: J Prim Care Community Health Date: 2022 Jan-Dec